APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Methotrexate Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Methotrexate Injection Industry Growth and Trends Forecast to 2032

Report ID 17401281012 January 2026105 pages

Choose your research edition.

Industry ResearchMethotrexate Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Methotrexate Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methotrexate Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Methotrexate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methotrexate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Methotrexate Injection include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Methotrexate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Methotrexate Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Methotrexate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Methotrexate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Methotrexate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Methotrexate Injection Market by Company

Accord

Get Well Pharmaceutical

Hikma

Fresenius Kabi

Guangdong Lingnan Pharma

Hengrui Medicine

Pfizer

Mylan

Qilu Pharmaceutical

Shanxi Pude Pharma

Sichuan Huiyu Pharma

Teva

Youcare Pharmaceutical Group

Methotrexate Injection Segment by Type

Preservative-Free

With Preservative

Methotrexate Injection Segment by Application

Specialty Clinic

Hospital

Recovry Center

Methotrexate Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Preservative-Free Table 2. Major Company of With Preservative Table 3. Global Methotrexate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 5. Global Methotrexate Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Methotrexate Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Methotrexate Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 10. Global Methotrexate Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Methotrexate Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Methotrexate Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Methotrexate Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 15. North America Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 17. Europe Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 21. Latin America Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Methotrexate Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Methotrexate Injection Industry Trends Table 25. Methotrexate Injection Industry Drivers Table 26. Methotrexate Injection Industry Opportunities and Challenges Table 27. Methotrexate Injection Industry Restraints Table 28. Global Methotrexate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Methotrexate Injection Revenue Market Share by Company (2021-2026) Table 30. Global Methotrexate Injection Sales by Company (2021-2026) & (W Units) Table 31. Global Methotrexate Injection Sales Share by Company (2021-2026) Table 32. Global Methotrexate Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Methotrexate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Methotrexate Injection Major Company Production Sites and Headquarters Table 35. Global Methotrexate Injection Company, Product Type & Application Table 36. Global Methotrexate Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Methotrexate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Methotrexate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Methotrexate Injection Sales by Region (2021-2026) & (W Units) Table 41. Global Methotrexate Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Methotrexate Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Methotrexate Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Methotrexate Injection Sales by Region (2027-2032) & (W Units) Table 46. Global Methotrexate Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Methotrexate Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Methotrexate Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Methotrexate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 52. Global Methotrexate Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Methotrexate Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Methotrexate Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 57. Global Methotrexate Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Methotrexate Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Methotrexate Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Methotrexate Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 62. North America Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 64. Europe Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 68. Latin America Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Methotrexate Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Accord Company Information Table 72. Accord Business Overview Table 73. Accord Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Accord Methotrexate Injection Product Portfolio Table 75. Accord Recent Development Table 76. Get Well Pharmaceutical Company Information Table 77. Get Well Pharmaceutical Business Overview Table 78. Get Well Pharmaceutical Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Get Well Pharmaceutical Methotrexate Injection Product Portfolio Table 80. Get Well Pharmaceutical Recent Development Table 81. Hikma Company Information Table 82. Hikma Business Overview Table 83. Hikma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Methotrexate Injection Product Portfolio Table 85. Hikma Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Methotrexate Injection Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Guangdong Lingnan Pharma Company Information Table 92. Guangdong Lingnan Pharma Business Overview Table 93. Guangdong Lingnan Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio Table 95. Guangdong Lingnan Pharma Recent Development Table 96. Hengrui Medicine Company Information Table 97. Hengrui Medicine Business Overview Table 98. Hengrui Medicine Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hengrui Medicine Methotrexate Injection Product Portfolio Table 100. Hengrui Medicine Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Methotrexate Injection Product Portfolio Table 105. Pfizer Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mylan Methotrexate Injection Product Portfolio Table 110. Mylan Recent Development Table 111. Qilu Pharmaceutical Company Information Table 112. Qilu Pharmaceutical Business Overview Table 113. Qilu Pharmaceutical Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Qilu Pharmaceutical Methotrexate Injection Product Portfolio Table 115. Qilu Pharmaceutical Recent Development Table 116. Shanxi Pude Pharma Company Information Table 117. Shanxi Pude Pharma Business Overview Table 118. Shanxi Pude Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shanxi Pude Pharma Methotrexate Injection Product Portfolio Table 120. Shanxi Pude Pharma Recent Development Table 121. Sichuan Huiyu Pharma Company Information Table 122. Sichuan Huiyu Pharma Business Overview Table 123. Sichuan Huiyu Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio Table 125. Sichuan Huiyu Pharma Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Teva Methotrexate Injection Product Portfolio Table 130. Teva Recent Development Table 131. Youcare Pharmaceutical Group Company Information Table 132. Youcare Pharmaceutical Group Business Overview Table 133. Youcare Pharmaceutical Group Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio Table 135. Youcare Pharmaceutical Group Recent Development Table 136. North America Methotrexate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. North America Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 138. North America Methotrexate Injection Sales Market Share by Country (2021-2026) Table 139. North America Methotrexate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 140. North America Methotrexate Injection Sales Market Share Forecast by Country (2027-2032) Table 141. North America Methotrexate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Methotrexate Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Methotrexate Injection Market Share by Country (2021-2026) Table 144. North America Methotrexate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Methotrexate Injection Market Share Forecast by Country (2027-2032) Table 146. Europe Methotrexate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Europe Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 148. Europe Methotrexate Injection Sales Market Share by Country (2021-2026) Table 149. Europe Methotrexate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 150. Europe Methotrexate Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Methotrexate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Methotrexate Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Methotrexate Injection Market Share by Country (2021-2026) Table 154. Europe Methotrexate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Methotrexate Injection Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Methotrexate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 158. Asia-Pacific Methotrexate Injection Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Methotrexate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 160. Asia-Pacific Methotrexate Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Methotrexate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Methotrexate Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Methotrexate Injection Market Share by Country (2021-2026) Table 164. Asia-Pacific Methotrexate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Methotrexate Injection Market Share Forecast by Country (2027-2032) Table 166. Latin America Methotrexate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 167. Latin America Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 168. Latin America Methotrexate Injection Sales Market Share by Country (2021-2026) Table 169. Latin America Methotrexate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 170. Latin America Methotrexate Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Methotrexate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Methotrexate Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Methotrexate Injection Market Share by Country (2021-2026) Table 174. Latin America Methotrexate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Methotrexate Injection Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Methotrexate Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 178. Middle East and Africa Methotrexate Injection Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Methotrexate Injection Sales Forecast by Country (2027-2032) & (W Units) Table 180. Middle East and Africa Methotrexate Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Methotrexate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Methotrexate Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Methotrexate Injection Market Share by Country (2021-2026) Table 184. Middle East and Africa Methotrexate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Methotrexate Injection Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Methotrexate Injection Distributors List Table 189. Methotrexate Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Methotrexate Injection Image Figure 2. Global Methotrexate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methotrexate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Methotrexate Injection Sales (2021-2032) & (W Units) Figure 5. Preservative-Free Image Figure 6. Global Preservative-Free Sales YoY Growth (2021-2032) & (W Units) Figure 7. With Preservative Image Figure 8. Global With Preservative Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Methotrexate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Methotrexate Injection Market Share by Type 2025 VS 2032 Figure 11. North America Methotrexate Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Methotrexate Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Methotrexate Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Methotrexate Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Methotrexate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Methotrexate Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Methotrexate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Methotrexate Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Methotrexate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Methotrexate Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Methotrexate Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Specialty Clinic Image Figure 24. Global Specialty Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Recovry Center Image Figure 28. Global Recovry Center Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Methotrexate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Methotrexate Injection Market Share by Application 2025 VS 2032 Figure 31. North America Methotrexate Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Methotrexate Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Methotrexate Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Methotrexate Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Methotrexate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Methotrexate Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Methotrexate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Methotrexate Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Methotrexate Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Methotrexate Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Methotrexate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Methotrexate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Methotrexate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Methotrexate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Methotrexate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Methotrexate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Methotrexate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Methotrexate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Methotrexate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Methotrexate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Methotrexate Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Methotrexate Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Preservative-Free
  • With Preservative
Applications
  • Specialty Clinic
  • Hospital
  • Recovry Center
Companies covered
  • Accord
  • Get Well Pharmaceutical
  • Hikma
  • Fresenius Kabi
  • Guangdong Lingnan Pharma
  • Hengrui Medicine
  • Pfizer
  • Mylan
  • Qilu Pharmaceutical
  • Shanxi Pude Pharma
  • Sichuan Huiyu Pharma
  • Teva
  • Youcare Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Methotrexate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Methotrexate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Methotrexate Injection Market by Type
  6. 1.3.1 Preservative-Free
  7. 1.3.2 With Preservative
  8. 1.4 Global Methotrexate Injection Market Size by Type
  9. 1.4.1 Global Methotrexate Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Methotrexate Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Methotrexate Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Methotrexate Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Methotrexate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Methotrexate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Methotrexate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Methotrexate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Methotrexate Injection Industry Trends
  2. 2.2 Methotrexate Injection Industry Drivers
  3. 2.3 Methotrexate Injection Industry Opportunities and Challenges
  4. 2.4 Methotrexate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Methotrexate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Methotrexate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Methotrexate Injection Price (2021-2026)
  4. 3.4 Global Methotrexate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Methotrexate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Methotrexate Injection Company, Product Type & Application
  7. 3.7 Global Methotrexate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Methotrexate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Methotrexate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Methotrexate Injection Tier 1, Tier 2, and Tier 3
4 Methotrexate Injection Regional Status and Outlook
  1. 4.1 Global Methotrexate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Methotrexate Injection Historic Market Size by Region
  3. 4.2.1 Global Methotrexate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Methotrexate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Methotrexate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Methotrexate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Methotrexate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Methotrexate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Methotrexate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Methotrexate Injection by Application
  1. 5.1 Methotrexate Injection Market by Application
  2. 5.1.1 Specialty Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovry Center
  5. 5.2 Global Methotrexate Injection Market Size by Application
  6. 5.2.1 Global Methotrexate Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Methotrexate Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Methotrexate Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Methotrexate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Methotrexate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Methotrexate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Methotrexate Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Methotrexate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Accord
  2. 6.1.1 Accord Company Information
  3. 6.1.2 Accord Business Overview
  4. 6.1.3 Accord Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Accord Methotrexate Injection Product Portfolio
  6. 6.1.5 Accord Recent Developments
  7. 6.2 Get Well Pharmaceutical
  8. 6.2.1 Get Well Pharmaceutical Company Information
  9. 6.2.2 Get Well Pharmaceutical Business Overview
  10. 6.2.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
  12. 6.2.5 Get Well Pharmaceutical Recent Developments
  13. 6.3 Hikma
  14. 6.3.1 Hikma Company Information
  15. 6.3.2 Hikma Business Overview
  16. 6.3.3 Hikma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Methotrexate Injection Product Portfolio
  18. 6.3.5 Hikma Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Guangdong Lingnan Pharma
  26. 6.5.1 Guangdong Lingnan Pharma Company Information
  27. 6.5.2 Guangdong Lingnan Pharma Business Overview
  28. 6.5.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
  30. 6.5.5 Guangdong Lingnan Pharma Recent Developments
  31. 6.6 Hengrui Medicine
  32. 6.6.1 Hengrui Medicine Company Information
  33. 6.6.2 Hengrui Medicine Business Overview
  34. 6.6.3 Hengrui Medicine Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hengrui Medicine Methotrexate Injection Product Portfolio
  36. 6.6.5 Hengrui Medicine Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Methotrexate Injection Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Methotrexate Injection Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Qilu Pharmaceutical
  50. 6.9.1 Qilu Pharmaceutical Company Information
  51. 6.9.2 Qilu Pharmaceutical Business Overview
  52. 6.9.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
  54. 6.9.5 Qilu Pharmaceutical Recent Developments
  55. 6.10 Shanxi Pude Pharma
  56. 6.10.1 Shanxi Pude Pharma Company Information
  57. 6.10.2 Shanxi Pude Pharma Business Overview
  58. 6.10.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
  60. 6.10.5 Shanxi Pude Pharma Recent Developments
  61. 6.11 Sichuan Huiyu Pharma
  62. 6.11.1 Sichuan Huiyu Pharma Company Information
  63. 6.11.2 Sichuan Huiyu Pharma Business Overview
  64. 6.11.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
  66. 6.11.5 Sichuan Huiyu Pharma Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Methotrexate Injection Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Youcare Pharmaceutical Group
  74. 6.13.1 Youcare Pharmaceutical Group Company Information
  75. 6.13.2 Youcare Pharmaceutical Group Business Overview
  76. 6.13.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
  78. 6.13.5 Youcare Pharmaceutical Group Recent Developments
7 North America by Country
  1. 7.1 North America Methotrexate Injection Sales by Country
  2. 7.1.1 North America Methotrexate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Methotrexate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Methotrexate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Methotrexate Injection Market Size by Country
  6. 7.2.1 North America Methotrexate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Methotrexate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Methotrexate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Methotrexate Injection Sales by Country
  2. 8.1.1 Europe Methotrexate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Methotrexate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Methotrexate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Methotrexate Injection Market Size by Country
  6. 8.2.1 Europe Methotrexate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Methotrexate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Methotrexate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Methotrexate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Methotrexate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Methotrexate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Methotrexate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Methotrexate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Methotrexate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Methotrexate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Methotrexate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Methotrexate Injection Sales by Country
  2. 10.1.1 South America Methotrexate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Methotrexate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Methotrexate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Methotrexate Injection Market Size by Country
  6. 10.2.1 South America Methotrexate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Methotrexate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Methotrexate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Methotrexate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Methotrexate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Methotrexate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Methotrexate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Methotrexate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Methotrexate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Methotrexate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Methotrexate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Methotrexate Injection Value Chain Analysis
  2. 12.1.1 Methotrexate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Methotrexate Injection Production Mode & Process
  7. 12.2 Methotrexate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Methotrexate Injection Distributors
  10. 12.2.3 Methotrexate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst